SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
14638597
Source:
http://linkedlifedata.com/resource/pubmed/id/14638597
Search
Subject
(
54
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0036341
,
umls-concept:C0237401
,
umls-concept:C0249458
,
umls-concept:C0301630
,
umls-concept:C1457887
pubmed:issue
12
pubmed:dateCreated
2003-11-25
pubmed:abstractText
The study was an investigation of the effect of the antiviral medication valacyclovir on the symptoms of outpatients with persistent schizophrenia.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0370512
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Acyclovir
,
http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Prodrugs
,
http://linkedlifedata.com/resource/pubmed/chemical/Valine
,
http://linkedlifedata.com/resource/pubmed/chemical/valacyclovir
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0002-953X
pubmed:author
pubmed-author:BoronowJohn JJJ
,
pubmed-author:DickersonFaith BFB
,
pubmed-author:OrigoniAndrea EAE
,
pubmed-author:StallingsCassie RCR
,
pubmed-author:YolkenRobert HRH
pubmed:issnType
Print
pubmed:volume
160
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2234-6
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:14638597-Acyclovir
,
pubmed-meshheading:14638597-Adult
,
pubmed-meshheading:14638597-Antiviral Agents
,
pubmed-meshheading:14638597-Cytomegalovirus Infections
,
pubmed-meshheading:14638597-Drug Therapy, Combination
,
pubmed-meshheading:14638597-Female
,
pubmed-meshheading:14638597-Follow-Up Studies
,
pubmed-meshheading:14638597-Humans
,
pubmed-meshheading:14638597-Male
,
pubmed-meshheading:14638597-Middle Aged
,
pubmed-meshheading:14638597-Prodrugs
,
pubmed-meshheading:14638597-Psychiatric Status Rating Scales
,
pubmed-meshheading:14638597-Psychotic Disorders
,
pubmed-meshheading:14638597-Schizophrenia
,
pubmed-meshheading:14638597-Schizophrenic Psychology
,
pubmed-meshheading:14638597-Treatment Outcome
,
pubmed-meshheading:14638597-Valine
pubmed:year
2003
pubmed:articleTitle
Reduction of symptoms by valacyclovir in cytomegalovirus-seropositive individuals with schizophrenia.
pubmed:affiliation
Stanley Division of Developmental Neurovirology, Johns Hopkins University, Blalock 1105, 600 N. Wolfe St., Baltimore, MD 21287-4933, USA.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Research Support, Non-U.S. Gov't